Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents and young adults

ABSTRACTThe multicomponent meningococcal serogroup B vaccine, 4CMenB, has demonstrated effectiveness in preventing invasive MenB disease in infants and in controlling MenB outbreaks. The need for/t...